Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-17-020844

Director sold 20,781 shares at $6.24 ($129,673)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lawrence Thomas R Director 2017-03-13 Sale −20,781 $6.24 $129,673 6,000 D
Open-market sales · 20,781 sh · avg $6.24 · $129,673
Loading xslF345X03/doc4.xml…